Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2019

Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy

Abstract

Platelets are small anucleate cells present in the blood stream, their typical role in primary hemostasis has been well-described. However, new evidence suggests that they have critically important roles in cancer progression and inflammation. Cancer cells can activate platelets, thus using them as physical shields from blood shear forces and natural killer (NK) cells. The activated platelets may also regulate hematopoietic and immune cell migration toward the tumor site; therefore, contributing to the cancer-associated inflammation. The activation of platelets by cancer cells may also contribute to metastasis and cancer progression by stimulating deep venous thrombosis and neutrophil extracellular trap formations (NETs) that “hide” cancer cells. We strived to review the current literature to dissect the role of platelets in cancer-associated thrombosis and tumor microenvironment inflammation.
Fichier principal
Vignette du fichier
fimmu-10-01805.pdf (872.86 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-02544297 , version 1 (16-04-2020)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Ana-Luisa Palacios Acedo, Diane Mege, Lydie Crescence, Francoise Dignat-George, Dubois Christophe, et al.. Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy. Frontiers in Immunology, 2019, 1, ⟨10.3389/fimmu.2019.01805⟩. ⟨hal-02544297⟩
76 View
76 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More